1-4 of 4
Lizi Wu, PhD
Close
Sort by
Journal Articles

CRM1 Blockade by Novel Inhibitors of Nuclear Export (SINEs) Inhibits Multiple Myeloma Cell Growth, Osteoclastogenesis, and Myeloma-Induced Osteolysis

Yu-Tzu Tai, PhD, Yosef Landesman, PhD, Chirag Acharya, M.D., Mike Y Zhong, B.S., Yolanda Calle, PhD, Michele Cea, MD, Yiguo Hu, PhD, Antonia Cagnetta, MD, Daniel Tannenbaum, B.S., Michelle Chen, Aditya Munshi, William Senapedis, PhD, Jean-Richard Saint-Martin, BS, Trinayan Kashyap, Haoqiang Ying, Dilara McCauley, PhD, Sharon Shacham, PhD MBA, Michael Kauffman, MD, PhD, Yumei Gu, Ph.D., Lizi Wu, PhD, Stephen Schey, MD, Andrew L. Kung, MD, PhD, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2012) 120 (21): 326.
https://doi.org/10.1182/blood.V120.21.326.326
Published: 2012
Journal Articles

Activation of Notch1 Signaling Suppresses Granulocytic Differentiation and Maintains a Part of Myeloid Progenitor Cells At the Immature Stage

Makoto Nakamura, MD, Lizi Wu, PhD, Satoru Kojika, MD, James D. Griffin, MD, Kanji Sugita, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2375.
https://doi.org/10.1182/blood.V118.21.2375.2375
Published: 2011
Journal Articles

Essential Role for the MAML1 Co-Activator In T-ALL

Chunxia Cao, Ph.D., Liang Tian, Jian-Liang Li, Ph.D., James D. Griffin, MD, Suming Huang, PhD, Lizi Wu, PhD
Journal: Blood
Blood (2010) 116 (21): 2501.
https://doi.org/10.1182/blood.V116.21.2501.2501
Published: 2010
Journal Articles

The MAML1 Transcriptional Co-Activator Is Required for the Development of Marginal Zone B Cells.

Lizi Wu, PhD, Ivan Maillard, Ph.D., Makoto Nakamura, M.D., Warren S. Pear, M.D. Ph.D., James D. Griffin, M.D.
Journal: Blood
Blood (2006) 108 (11): 777.
https://doi.org/10.1182/blood.V108.11.777.777
Published: 2006